Spots Global Cancer Trial Database for t lymphocytes
Every month we try and update this database with for t lymphocytes cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL | NCT03602157 | Lymphoma Immune System D... Immunoprolifera... Lymphatic Disea... Lymphoprolifera... Neoplasms Cutaneous Lymph... Cutaneous Anapl... Mycosis Fungoid... Sezary Syndrome Lymphomatoid Pa... Cutaneous T Cel... Gray Zone Lymph... | ATLCAR.CD30.CCR... ALTCAR.CD30 cel... Bendamustine Fludarabine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells | NCT00562666 | Hepatocellular ... | T gamma delta l... | 18 Years - | Rennes University Hospital | |
Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes | NCT00953420 | Nasopharyngeal ... | Docetaxel Carboplatin Dexamethasone EBV-specific cy... G-CSF or Peg-GC... | 10 Years - | Baylor College of Medicine | |
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL | NCT02690545 | Lymphoma Lymphoma, Non-H... Immune System D... Immunoprolifera... Lymphatic Disea... Lymphoprolifera... Neoplasms Neoplasms by Hi... | ATLCAR.CD30 cel... | 3 Years - | UNC Lineberger Comprehensive Cancer Center | |
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients | NCT01336270 | Melanoma | biological coll... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL | NCT03016377 | Acute Lymphobla... Immune System D... Immunoprolifera... | iC9-CAR19 cells Rimiducid Cyclophosphamid... Fludarabine | 3 Years - 70 Years | UNC Lineberger Comprehensive Cancer Center | |
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas | NCT02663297 | Hodgkin Disease Lymphoma Lymphoma, Non-H... Immune System D... Immunoprolifera... Lymphatic Disea... Lymphoprolifera... Neoplasms Neoplasms by Hi... | ATLCAR.CD30 cel... | 3 Years - | UNC Lineberger Comprehensive Cancer Center | |
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | NCT04223765 | Mantle Cell Lym... Follicular Lymp... Splenic Margina... Extranodal Marg... Nodal Marginal ... Indolent Non-ho... | CAR.k.28 Fludarabine Cyclophosphamid... Bendamustine | 18 Years - | UNC Lineberger Comprehensive Cancer Center |